[go: up one dir, main page]

Kazama et al., 2008 - Google Patents

New insulin sensitivity index from the oral glucose tolerance test

Kazama et al., 2008

View PDF
Document ID
13681188762018328544
Author
Kazama Y
Takamura T
Sakurai M
Shindo H
Ohkubo E
Aida K
Harii N
Taki K
Kaneshige M
Tanaka S
Shimura H
Endo T
Kobayashi T
Publication year
Publication venue
diabetes research and clinical practice

External Links

Snippet

A new insulin sensitivity index was devised on the basis of an autoregressive model and its validity was investigated. Using data from the 75-g oral glucose tolerance test (OGTT), 115 subjects were divided into 3 groups: 40 with normal glucose tolerance, 34 with impaired …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Similar Documents

Publication Publication Date Title
Liu et al. Associations of serum folate and vitamin B12 levels with cardiovascular disease mortality among patients with type 2 diabetes
Moser et al. Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trial
Knaeps et al. Ten-year change in sedentary behaviour, moderate-to-vigorous physical activity, cardiorespiratory fitness and cardiometabolic risk: independent associations and mediation analysis
Lee et al. Trends in metabolic syndrome severity and lifestyle factors among adolescents
Rankinen et al. Advances in exercise, fitness, and performance genomics
Cauza et al. Strength and endurance training lead to different post exercise glucose profiles in diabetic participants using a continuous subcutaneous glucose monitoring system
Bastard et al. Relationship between the hyperinsulinemic–euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women
Kazama et al. New insulin sensitivity index from the oral glucose tolerance test
Piona et al. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes
Kulawiec et al. Continuous glucose monitoring to measure metabolic impact and recovery in sub-elite endurance athletes
Telford et al. Sensitivity of blood lipids to changes in adiposity, exercise, and diet in children
Staimez et al. Potential misclassification of diabetes and prediabetes in the US: mismatched HbA1c and glucose in NHANES 2005–2016
Liu et al. Clustering of cardio-metabolic risk factors and pre-diabetes among US adolescents
Cheng et al. Cumulative HbA1c exposure as a CVD risk in patients with type 2 diabetes: A post hoc analysis of ACCORD trial
Kesavadev et al. Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM
McNarry et al. Influence of exercise intensity on pulmonary oxygen uptake kinetics in young and late middle-aged adults
Brennan et al. Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis
Kakutani-Hatayama et al. Associations of sleep quality, sleep apnea and autonomic function with insulin secretion and sensitivity: HSCAA study
Zhao et al. The predictive significance of the triglyceride-glucose index in forecasting adverse cardiovascular events among type 2 diabetes mellitus patients with co-existing hyperuricemia: a retrospective cohort study
Wei et al. Interaction of sex and diabetes on the association between hemoglobin glycation index, hemoglobin A1c and serum uric acid
Xiao et al. Non-linear relationship between relative fat mass and diabetes risk in Japanese adults: a retrospective cohort study
Matzka et al. Accuracy of a continuous glucose monitoring system applied before, during, and after an intense leg-squat session with low-and high-carbohydrate availability in young adults without diabetes
Wang et al. A national study exploring the association between triglyceride-glucose index and risk of hyperuricemia events in adults with hypertension
Ye et al. Time in range assessed by capillary blood glucose in relation to insulin sensitivity and β‐cell function in patients with type 2 diabetes mellitus: A cross‐sectional study in China
Kargotich et al. Plasma glutamine responses to high-intensity exercise before and after endurance training